Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

1-25 of 38 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Phenotyping <i>in vivo</i> chronic inflammation in multiple sclerosis by combined <sup>11</sup>C-PBR28 MR-PET and 7T susceptibility-weighted imaging.
Treaba CA, Herranz E, Barletta VT, Mehndiratta A, Sloane JA, Granberg T, Miscioscia A, Bomprezzi R, Loggia ML, Mainero C
Mult Scler, 13524585241284157, 22 Oct 2024
Cited by: 0 articles | PMID: 39436837
Add to export list
Cervical spondylosis is a risk factor for localized spinal cord lesions in multiple sclerosis.
Bomprezzi R, Chen AP, Hemond CC
Clin Neurol Neurosurg, 199:106311, 15 Oct 2020
Cited by: 1 article | PMID: 33091657
Add to export list
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA, CARE-MS II Investigators
Neurology, 87(19):1985-1992, 12 Oct 2016
Cited by: 34 articles | PMID: 27733571 | PMCID: PMC5109953
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Extended interval dosing of natalizumab in multiple sclerosis.
Zhovtis Ryerson L, Frohman TC, Foley J, Kister I, Weinstock-Guttman B, Tornatore C, Pandey K, Donnelly S, Pawate S, Bomprezzi R, Smith D, Kolb C, Qureshi S, Okuda D, Kalina J, Rimler Z, Green R, Monson N, Hoyt T, [...] Frohman EM
J Neurol Neurosurg Psychiatry, 87(8):885-889, 25 Feb 2016
Cited by: 68 articles | PMID: 26917698
Add to export list
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.
Govindarajan KA, Datta S, Hasan KM, Choi S, Rahbar MH, Cofield SS, Cutter GR, Lublin FD, Wolinsky JS, Narayana PA, MRI Analysis Center at Houston, CombiRx Investigators Group
Hum Brain Mapp, 36(10):3749-3760, 19 Jun 2015
Cited by: 13 articles | PMID: 26096844 | PMCID: PMC4839289
Add to export list Free full text in Europe PMC
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview.
Bomprezzi R
Ther Adv Neurol Disord, 8(1):20-30, 01 Jan 2015
Cited by: 148 articles | PMID: 25584071 | PMCID: PMC4286944
Add to export list Review Free full text in Europe PMC
Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center data.
Datta S, Staewen TD, Cofield SS, Cutter GR, Lublin FD, Wolinsky JS, Narayana PA, MRI Analysis Center at Houston, CombiRx Investigators Group
Mult Scler Relat Disord, 4(2):124-136, 17 Jan 2015
Cited by: 17 articles | PMID: 25787188 | PMCID: PMC4366621
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT, CONFIRM study investigators
Neurology, 84(11):1145-1152, 13 Feb 2015
Cited by: 42 articles | PMID: 25681448 | PMCID: PMC4371413
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Are randomized, blind clinical trials enough to guide individualized decisions for patients with neurologic diseases?
Alderazi YJ, Bomprezzi R
Neurol Clin Pract, 4(4):319-328, 01 Aug 2014
Cited by: 1 article | PMID: 29473563 | PMCID: PMC5764529
Add to export list Free full text in Europe PMC
Extended interval dosing of natalizumab: a two-center, 7-year experience.
Bomprezzi R, Pawate S
Ther Adv Neurol Disord, 7(5):227-231, 01 Sep 2014
Cited by: 39 articles | PMID: 25342976 | PMCID: PMC4206618
Add to export list Free full text in Europe PMC
Demyelinating disease and psoriasis: interferon versus dimethyl fumarate.
Howard LG, Bomprezzi R
J Neurol Sci, 343(1-2):230-231, 27 May 2014
Cited by: 1 article | PMID: 24906711
Add to export list
Randomized study combining interferon and glatiramer acetate in multiple sclerosis.
Lublin FD, Cofield SS, Cutter GR, Conwit R, Narayana PA, Nelson F, Salter AR, Gustafson T, Wolinsky JS, CombiRx Investigators
Ann Neurol, 73(3):327-340, 11 Mar 2013
Cited by: 120 articles | PMID: 23424159 | PMCID: PMC3631288
Add to export list Free full text in Europe PMC
Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis.
Sun F, Ladha SS, Yang L, Liu Q, Shi SX, Su N, Bomprezzi R, Shi FD
Muscle Nerve, 49(4):487-494, 27 Feb 2014
Cited by: 51 articles | PMID: 23868194
Add to export list
Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing.
Burgos KL, Javaherian A, Bomprezzi R, Ghaffari L, Rhodes S, Courtright A, Tembe W, Kim S, Metpally R, Van Keuren-Jensen K
RNA, 19(5):712-722, 22 Mar 2013
Cited by: 132 articles | PMID: 23525801 | PMCID: PMC3677285
Add to export list Free full text in Europe PMC
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA, CARE-MS II investigators
Lancet, 380(9856):1829-1839, 01 Nov 2012
Cited by: 604 articles | PMID: 23122650
Add to export list
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT, CONFIRM Study Investigators
N Engl J Med, 367(12):1087-1097, 01 Sep 2012
Cited by: 765 articles | PMID: 22992072
Add to export list
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
Cohen JA, Coles AJ, Arnold DL, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Fisher E, Brinar VV, Giovannoni G, Stojanovic M, Ertik BI, Lake SL, Margolin DH, Panzara MA, Compston DA, CARE-MS I investigators
Lancet, 380(9856):1819-1828, 01 Nov 2012
Cited by: 615 articles | PMID: 23122652
Add to export list
Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
Gan Y, Liu R, Wu W, Bomprezzi R, Shi FD
J Neuroimmunol, 247(1-2):9-15, 13 Apr 2012
Cited by: 17 articles | PMID: 22503411 | PMCID: PMC3351567
Add to export list Free full text in Europe PMC
IFNβ-1b may severely exacerbate Japanese opticspinal MS in neuromyelitis optica spectrum: Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment?
Bomprezzi R, Powers JM, Shimizu J, Tsuji S, Weinshenker BG, Wingerchuk DM
Neurology, 77(2):195; discussion 195-6, 01 Jul 2011
Cited by: 3 articles | PMID: 21747078
Add to export list
From injection therapies to natalizumab: views on the treatment of multiple sclerosis.
Bomprezzi R, Okuda DT, Alderazi YJ, Stüve O, Frohman EM
Ther Adv Neurol Disord, 5(2):97-104, 01 Mar 2012
Cited by: 4 articles | PMID: 22435074 | PMCID: PMC3302200
Add to export list Free full text in Europe PMC
Glatiramer acetate-specific antibody titres in patients with relapsing / remitting multiple sclerosis and in experimental autoimmune encephalomyelitis.
Bomprezzi R, Schaefer R, Reese V, Misra A, Vollmer TL, Kala M
Scand J Immunol, 74(3):219-226, 01 Sep 2011
Cited by: 6 articles | PMID: 21615449
Add to export list
Head tremor secondary to MS resolved with rituximab.
Chansakul C, Moguel-Cobos G, Bomprezzi R
Neurol Sci, 32(6):1157-1160, 10 May 2011
Cited by: 2 articles | PMID: 21556869
Add to export list
A case of neurosarcoidosis successfully treated with rituximab.
Bomprezzi R, Pati S, Chansakul C, Vollmer T
Neurology, 75(6):568-570, 01 Aug 2010
Cited by: 38 articles | PMID: 20697110
Add to export list
Demyelinating disease and polyvalent human papilloma virus vaccination.
Chang J, Campagnolo D, Vollmer TL, Bomprezzi R
J Neurol Neurosurg Psychiatry, 82(11):1296-1298, 09 Oct 2010
Cited by: 18 articles | PMID: 20935322
Add to export list
A review of cases of neuromyelitis optica.
Bomprezzi R, Postevka E, Campagnolo D, Vollmer TL
Neurologist, 17(2):98-104, 01 Mar 2011
Cited by: 5 articles | PMID: 21364364
Add to export list Review

1-25 of 38 results

1 2

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

Partnerships & funding